Abstract: Disclosed herein are phosphor compositions having high gadolinium concentrations. Some embodiments include a thermally stable ceramic body comprising an emissive layer, wherein said emissive layer comprises a compound represented by the formula (A1-x-zGdxDz)3B5O12, wherein: D is a first dopant selected from the group consisting of Nd, Er, Eu, Mn, Cr, Yb, Sm, Tb, Ce, Pr, Dy, Ho, Lu and combinations thereof; A is selected from the group consisting of Y, Lu, Ca, La, Tb, and combinations thereof; B is selected from the group consisting of Al, Mg, Si, Ga, In, and combinations thereof; x is in the range of about 0.20 and about 0.80; and z is in the range of about 0.001 and about 0.10. Also disclosed are thermally stable ceramic bodies that can include the composition of formula I. Methods of making the ceramic body and a lighting device including the ceramic body are also disclosed.

Abstract: Methods and devices related to the treatment of diseases using phototherapy are described. Some embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising Ring system 1, Ring system 2, Ring system 3, or Ring system 4. Methods of treating disease with phototherapy are also described.

Abstract: A light emitting device comprising a light emitting component that emits light with a first peak wavelength, and at least one sintered ceramic plate over the light emitting component is described. The at least one sintered ceramic plate is capable of absorbing at least a portion of the light emitted from said light emitting component and emitting light of a second peak wavelength, and has a total light transmittance at the second peak wavelength of greater than about 40%. A method for improving the luminance intensity of a light emitting device comprising providing a light emitting component and positioning at least one translucent sintered ceramic plate described above over the light emitting component is also disclosed.

Abstract: Optionally substituted bipyridine compounds, optionally substituted phenylbipyridine compounds, or optionally substituted bis-phenylbipyridine compounds may be useful in light-emitting devices.

Abstract: Disclosed herein are processes for making a plurality of substantially phase-pure metal oxide particles, the particles comprising a garnet structure, the process comprising: subjecting a dispersion of precursors to a solvothermal treatment to form a garnet intermediate and applying a flow-based thermochemical process to said garnet intermediate.

Abstract: Disclosed herein are emissive ceramic materials having a dopant concentration gradient along a thickness of a yttrium aluminum garnet (YAG) region. The dopant concentration gradient may include a maximum dopant concentration, a half-maximum dopant concentration, and a slope at or near the half-maximum dopant concentration. The emissive ceramics may, in some embodiments, exhibit high internal quantum efficiencies (IQE). The emissive ceramics may, in some embodiments, include porous regions. Also disclosed herein are methods of make the emissive ceramic by sintering an assembly having doped and non-doped layers.

Abstract: Emissive constructs having three emissive layers, each having the same fluorescent host are described. At least one of the layers further includes a phosphorescent dopant. Light-emitting devices including these emissive constructs are also described.

Abstract: Disclosed herein is a method of increasing the luminescence efficiency of a translucent phosphor ceramic. Other embodiments are methods of manufacturing a phosphor translucent ceramic having increased luminescence. Another embodiment is a light emitting device comprising a phosphor translucent ceramic made by one of these methods.

Abstract: A light emitting device comprising a light emitting component that emits light with a first peak wavelength, and at least one sintered ceramic plate over the light emitting component is described. The at least one sintered ceramic plate is capable of absorbing at least a portion of the light emitted from said light emitting component and emitting light of a second peak wavelength, and has a total light transmittance at the second peak wavelength of greater than about 40%. A method for improving the luminance intensity of a light emitting device comprising providing a light emitting component and positioning at least one translucent sintered ceramic plate described above over the light emitting component is also disclosed.

Abstract: Disclosed herein are a laminated composite and process for making the same. The laminated composite includes at least one wavelength-converting layer and at least one non-emissive layer, wherein a vertical relief gap pattern defines the composite into a plurality of discrete separable portions, and the discrete separable portions are breakably joined by a non-emissive layer. Separation along the relief gap pattern reduces color variation amongst the discrete portions and processes.

Abstract: Disclosed herein is a method of increasing the luminescence efficiency of a translucent phosphor ceramic. Other embodiments are methods of manufacturing a phosphor translucent ceramic having increased luminescence. Another embodiment is a light emitting device comprising a phosphor translucent ceramic made by one of these methods.

Abstract: Described herein are batches of nanoscale phosphor particles having an average particle size of less than about 200 nm and an average internal quantum efficiency of at least 40%. The batches of nanoscale phosphor particles can be substantially free of impurities. Also described herein are methods of manufacturing the nanoscale phosphor particles by passing phosphor particles through a reactive field to thereby dissociate them into elements and then synthesizing nanoscale phosphor particles by nucleating the elements and quenching the resulting particles.

Abstract: One embodiment provides a method for fabricating a translucent phosphor ceramic compact comprising: heating a precursor powder to at least about 1000° C. under a reducing atmosphere to provide a pre-conditioned powder, forming an intermediate compact comprising the pre-conditioned powder and a flux material, and heating the intermediate compact under a vacuum to a temperature of at least about 1400° C. In another embodiment, the compact may be a cerium doped translucent phosphor ceramic compact comprising yttrium, aluminum, oxygen, and cerium sources. Another embodiment may be a light emitting device having the phosphor translucent ceramic provided as described herein.

Abstract: Some embodiments provide a compound represented by Formula 2B: wherein Ph1 and Ph2 are independently optionally substituted 1,4-interphenylene or optionally substituted 1,3-interphenylene, y may be 0 or 1, and z may be 0 or 1. In some embodiments, R9 and R10 are independently H, C1-3 alkyl, or C1-3 perfluoroalkyl. In some embodiments, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, and R22 are independently selected from the group consisting of H, C1-12 alkyl, C1-6F1-13 fluoroalkyl, and optionally substituted phenyl. Other embodiments provide an organic light-emitting diode device comprising a compound of Formula 2B.

Abstract: Methods and devices related to the treatment of diseases using phototherapy are described. Some embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising a compound of Formula 1. Methods of treating disease diseases with phototherapy are also described.

Abstract: Disclosed herein are compounds represented by a formula: R1—Ar1—X—Ar2—Ar3-Het, wherein R1, Ar1, X, Ar2, Ar3, and Het are described herein. Compositions and light-emitting devices related thereto are also disclosed.

Abstract: Some embodiments provide a compound represented by Formula 1. Other embodiments provide an organic light-emitting diode device, such as a light-emitting device for phototherapy, comprising a compound of Formula 1. Other embodiments provide an organic light-emitting device optionally comprising a wavelength convertor. Methods related to the treatment of diseases using phototherapy area also described.

Abstract: A transparent electrically-conductive hard-coated substrate of the invention comprises a transparent base material; a deposited carbon nanotubes layer formed on the transparent base material; and a cured resin layer formed on the deposited carbon nanotubes layer, wherein the deposited carbon nanotubes layer has a thickness of 10 nm or less, the total thickness of the deposited carbon nanotubes layer and the cured resin layer is 1.5 ?m or more, and part of the deposited carbon nanotubes layer is diffused into the cured resin layer so that carbon nanotubes are present in the cured resin layer. The transparent electrically-conductive hard-coated substrate possesses high transparency and hard coating properties and also has electrical conductivity.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.

Abstract: Some embodiments provide a compound represented by Formula 1: wherein R1, R2, R3, R6, R7, and R8 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; provided that: at least one of R1, R2, and R3 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl and at least one of R6, R7, and R8 is selected from optionally substituted carbazolyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl; and R4 and R5 are independently selected from the group consisting of H, optionally substituted C1-12 alkyl, optionally substituted phenyl, optionally substituted diphenylamine and optionally substituted diphenylaminophenyl.